Document is current
Any future updates will be listed below
-
Authors
Goldman-Mazur, Sarah
Visram, Alissa
Rajkumar, S. Vincent https://orcid.org/0000-0002-5862-1833
Kapoor, Prashant https://orcid.org/0000-0002-4342-364X
Dispenzieri, Angela https://orcid.org/0000-0001-8780-9512
Lacy, Martha Q.
Gertz, Morie A. https://orcid.org/0000-0002-3853-5196
Buadi, Francis K. https://orcid.org/0000-0003-3214-0203
Hayman, Suzanne R.
Dingli, David https://orcid.org/0000-0001-7477-3004
Kourelis, Taxiarchis https://orcid.org/0000-0001-8573-9434
Gonsalves, Wilson
Warsame, Rahma
Muchtar, Eli https://orcid.org/0000-0003-2210-2174
Leung, Nelson
Kyle, Robert A.
Kumar, Shaji K. https://orcid.org/0000-0001-5392-9284
- License Information
-
More Information
Article History
Received: 24 August 2022
Revised: 2 November 2022
Accepted: 14 November 2022
First Online: 6 December 2022
Competing interests
: Prashant Kapoor: Research Funding: Takeda, Sanofi, Karyopharm, Glaxo SmithKline, Regeneron Pharmaceuticals, Ichnos Sciences, Amgen. Consultancy: Sanofi, Pharmacyclics, BeiGene, Cellectar, Karyopharm. Angela Dispenzieri: Consultancy and Research Funding: Janssen. Research Funding: Takeda, Alnylam, Pfizer. Consultancy: Oncopeptides, Sorrento Therapeutics. Morie A. Gertz, M.D: Advisory Board: Ionis Pharmaceuticals. Consultancy: Akcea Therapeutics, Alnylam Pharmaceuticals Inc, Prothena. Data Safety & Monitoring: AbbVie Inc, Celgene Corporation. Honoraria: Akcea Therapeutics, Ambry Genetics, Amgen Inc, Celgene Corporation, Janssen Biotech Inc, Karyopharm Therapeutics, Pfizer Inc (to Institution), Sanofi Genzyme. Stock option: Aurora Biopharma. David Dingli: Consultancy: Alexion, Apellis, GSK, Sanofi, Janssen. Research Funding: Novartis. Shaji Kumar: Consultancy and Research Funding: BMS, Amgen, Roche-Genentech. Consultancy, Membership on an entity’s Board of Directors or advisory committees, and Research Funding: Abbvie, Takeda, Janssen, KITE, Astra-Zeneca. Research Funding: Tenebio, Carsgen, Merck, Novartis, Sanofi. Consultancy: Beigene, Oncopeptides, Bluebird Bio. Consultancy and Honoraria: Antengene. Membership on an entity’s Board of Directors or advisory committees and Research Funding: Adaptive, Celgene.
